TGFB1 and cancer: Importantly, inhibition of TGF-β signaling activity effectively suppressed lymphatic metastasis of NSCLC (Salvo et al. 2014), implying that therapeutic strategy targeting TGF-β signaling holds favorable prospects for the treatment of lymphatic metastasis of cancer.